Dr. William E. Smiddy, MD

Dr. Smiddy practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Smiddy's NPI, 1346265337, was assigned on July 12, 2006. Dr. Smiddy graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Smiddy holds Florida license ME54809.

Dr. Smiddy's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Smiddy's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Smiddy is also affiliated with Baptist Health Doctors Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Smiddy to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smiddy practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Smiddy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Smiddy is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Smiddy's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and inflammation of iris among the conditions Dr. Smiddy treats.

CMS data shows 11,192 Medicare services from Dr. Smiddy across 24 procedure codes in 2024, for 1,783 Medicare patients. Medicare paid $1,299,364 for them.

CMS counts 1,783 Medicare patients who saw Dr. Smiddy in 2024. The largest group is 75 to 84, with 764 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Smiddy's median patient age at 74, with 50% women.

In 2024, Dr. Smiddy wrote 1,309 Medicare Part D claims for 467 patients. 68% of them were for generic drugs. CMS names the drug for 1,219 of them, across 12 drugs with 11 or more claims each, at $55,998 in total drug cost. In 2023, CMS named 971 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Smiddy for performance year 2024, reported as part of a group. Dr. Smiddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smiddy as offering telehealth. CMS counts 53 procedures of cataract surgery by Dr. Smiddy, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 308 papers to Dr. Smiddy, published from 2006 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Visual Acuity, Vitrectomy and Retinal Detachment. Dr. Smiddy has published most often in Retina. Dr. Smiddy's most frequent co-authors are Harry W. Flynn, MD, Nicolas A. Yannuzzi, MD and Timothy G. Murray, MBA, MD.

CMS Open Payments shows 29 general payments to Dr. Smiddy from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Genentech, Inc. paid the most, $458.

Dmand AI lists 3 awards for Dr. Smiddy, most recently CMS Stage 1 EHR in 2014.

Dr. Smiddy graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Smiddy is a member of AAO.

Dr. Smiddy is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.